Back to results
US 8,278,429 B2Granted
Oligonucleotide amplification primers for targeting oncogenic HPV
AssigneeGenera Biosystems Limited
InventorsDaniel J. Park, Zaheer Khan, Karl F. Poetter
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to the field of diagnostic and detection assays. More particularly, the present invention provides methods and reagents including biochips for detecting the presence of, or distinguishing between, one or more analytes in a sample.
Claims24
A forward and reverse primer pair for targeting oncogenic HPV, wherein:
- the forward primer of the primer pair is /5Phos/ggaacaatca rytrtttgtt actgtkgtdg a (SEQ ID NO:
- 36) or SEQ ID NO:
- 36 wherein the 5′ g nucleotide is not phosphorylated;
- and
- the reverse primer of the primer pair is SEQ ID NO:
- 9, wherein the reverse primer is optionally conjugated to a heel at the 5′ terminus of the reverse primer.
3 more elements
Dependencies are inferred from the claim text.